How to Get Approved for Wegovy for Weight Loss

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) has become one of the most sought-after weight loss medications, with clinical trials showing patients lose an average of 15% of body weight over 68 weeks. However, traditional Wegovy approval can be complicated by insurance requirements, supply shortages, and strict eligibility criteria. PlexusDx provides a streamlined path to semaglutide therapy through licensed 503A compounding pharmacies, making this proven GLP-1 receptor agonist accessible nationwide without insurance requirements.

What Are the Official Approval Requirements for Wegovy?

Wegovy approval through traditional channels requires meeting specific FDA-established criteria. You must have a body mass index (BMI) of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher combined with at least one weight-related condition such as type 2 diabetes, high blood pressure, or sleep apnea. Your healthcare provider must document that you have attempted lifestyle modifications without sufficient weight loss before prescribing Wegovy.

Insurance coverage adds another layer of complexity to the approval process. Many insurance plans classify Wegovy as a cosmetic weight loss drug rather than a medical necessity, leading to denials or high out-of-pocket costs. Prior authorization requirements can delay treatment by weeks or months, during which time patients may lose motivation or experience worsening metabolic health. The FDA-approved Wegovy is also frequently on backorder, leaving many patients without access to treatment even after approval.

Why Compounded Semaglutide Offers a Faster Alternative Path

Compounded semaglutide delivers the same active pharmaceutical ingredient as Wegovy but comes from licensed 503A compounding pharmacies rather than manufacturers. This distinction means PlexusDx can serve all 50 states immediately, without insurance gatekeeping or supply chain delays. The medication undergoes the same quality controls and pharmaceutical standards as brand-name versions, ensuring safety and efficacy for patients who meet clinical criteria.

PlexusDx streamlines the approval process by working directly with patients and licensed practitioners to assess suitability based on your health history, current weight, and metabolic goals. You avoid the insurance approval waiting period entirely, and treatment can often begin within days rather than weeks. Compounded semaglutide injections start at just $189/mo (or $149/mo on the 6-month plan), making it significantly more affordable than many insurance copays for Wegovy.

How PlexusDx Determines Your Eligibility for Semaglutide Therapy

PlexusDx evaluates candidates for compounded semaglutide using clinical guidelines that mirror FDA standards while removing insurance barriers. During your initial consultation, you'll be asked about your BMI, medical history, previous weight loss attempts, and any weight-related conditions. Your practitioner will review current medications and potential contraindications to ensure semaglutide is appropriate for your individual health profile.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Getting Started With Compounded Semaglutide at PlexusDx

Starting compounded semaglutide through PlexusDx requires minimal steps compared to traditional insurance-based approval. First, you'll complete a brief health assessment and connect with a licensed practitioner who reviews your eligibility. If you're a suitable candidate, your prescription is sent to a licensed 503A compounding pharmacy, and your first shipment typically arrives within 7–10 business days.

Your dose may need to go up over time as your body adjusts to treatment, but your monthly price remains flat at $149—no hidden costs or surprise copays. PlexusDx accepts HSA and FSA payments, and no membership fee is required. You maintain direct communication with your care team throughout your weight loss journey, with ongoing support to monitor your progress and adjust your treatment plan as needed.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Can I get approved for Wegovy if I don't meet the BMI requirement?

Traditional Wegovy approval is strict about BMI thresholds, but PlexusDx evaluates semaglutide eligibility more holistically. If you have significant weight-related health concerns, metabolic risk factors, or unsuccessful prior weight loss attempts, a licensed practitioner may determine that compounded semaglutide is medically appropriate for you even if your BMI is slightly below 30.

How much weight can I expect to lose with compounded semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is compounded semaglutide as safe as brand-name Wegovy?

Compounded semaglutide from PlexusDx comes from licensed 503A compounding pharmacies that follow strict pharmaceutical standards identical to those for FDA-approved medications. The active ingredient is identical to Wegovy; the only difference is the source. Both forms carry the same potential side effects (nausea, constipation, headache) and require the same medical oversight and monitoring.

Why is PlexusDx semaglutide so affordable compared to Wegovy?

PlexusDx pricing is $189 per month month-to-month, or from $149/mo on the 6-month plan because compounded medications bypass manufacturer markups and insurance middleman costs. You pay directly for the medication without copays, deductibles, or prior authorization fees. This direct-to-patient model makes GLP-1 therapy affordable for everyone, and your price never increases as your dose increases.

What does the Precision Peptide Genetic Test tell me about my semaglutide response?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.